| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | histone modifying activity | 5.07e-06 | 229 | 39 | 6 | GO:0140993 | |
| GeneOntologyMolecularFunction | modification-dependent protein binding | 4.82e-05 | 206 | 39 | 5 | GO:0140030 | |
| GeneOntologyMolecularFunction | polyubiquitin modification-dependent protein binding | 2.08e-04 | 59 | 39 | 3 | GO:0031593 | |
| GeneOntologyMolecularFunction | transcription coactivator activity | 2.94e-04 | 303 | 39 | 5 | GO:0003713 | |
| GeneOntologyMolecularFunction | chromatin DNA binding | 3.09e-04 | 167 | 39 | 4 | GO:0031490 | |
| GeneOntologyMolecularFunction | transcription coregulator activity | 7.16e-04 | 562 | 39 | 6 | GO:0003712 | |
| GeneOntologyMolecularFunction | methyl-CpG binding | 1.67e-03 | 31 | 39 | 2 | GO:0008327 | |
| GeneOntologyMolecularFunction | cyclin binding | 2.12e-03 | 35 | 39 | 2 | GO:0030332 | |
| GeneOntologyBiologicalProcess | positive regulation of transcription by RNA polymerase II | PAXIP1 SOX6 NFYC UHRF1 KMT2C ZFHX3 TCF20 MGA CLOCK CREBBP CDK12 GABPB1 TOX3 | 6.17e-07 | 1390 | 38 | 13 | GO:0045944 |
| GeneOntologyBiologicalProcess | circadian regulation of gene expression | 1.08e-05 | 75 | 38 | 4 | GO:0032922 | |
| GeneOntologyBiologicalProcess | rhythmic process | 4.67e-05 | 360 | 38 | 6 | GO:0048511 | |
| GeneOntologyBiologicalProcess | circadian rhythm | 8.76e-05 | 248 | 38 | 5 | GO:0007623 | |
| GeneOntologyBiologicalProcess | regulation of circadian rhythm | 1.09e-04 | 135 | 38 | 4 | GO:0042752 | |
| GeneOntologyBiologicalProcess | regulation of DNA-binding transcription factor activity | 1.57e-04 | 449 | 38 | 6 | GO:0051090 | |
| GeneOntologyCellularComponent | transcription regulator complex | 1.22e-04 | 596 | 40 | 7 | GO:0005667 | |
| GeneOntologyCellularComponent | MLL3/4 complex | 2.33e-04 | 12 | 40 | 2 | GO:0044666 | |
| GeneOntologyCellularComponent | histone methyltransferase complex | 3.98e-04 | 75 | 40 | 3 | GO:0035097 | |
| GeneOntologyCellularComponent | outer kinetochore | 9.59e-04 | 24 | 40 | 2 | GO:0000940 | |
| GeneOntologyCellularComponent | nuclear protein-containing complex | 9.66e-04 | 1377 | 40 | 9 | GO:0140513 | |
| GeneOntologyCellularComponent | methyltransferase complex | 1.15e-03 | 108 | 40 | 3 | GO:0034708 | |
| GeneOntologyCellularComponent | chromatin | 1.61e-03 | 1480 | 40 | 9 | GO:0000785 | |
| GeneOntologyCellularComponent | RNA polymerase II transcription regulator complex | 1.77e-03 | 272 | 40 | 4 | GO:0090575 | |
| Domain | Ubiquilin | 1.81e-07 | 6 | 40 | 3 | IPR015496 | |
| Domain | UBQ | 2.10e-06 | 43 | 40 | 4 | SM00213 | |
| Domain | ubiquitin | 3.01e-06 | 47 | 40 | 4 | PF00240 | |
| Domain | UBIQUITIN_2 | 5.28e-06 | 54 | 40 | 4 | PS50053 | |
| Domain | Ubiquitin_dom | 7.04e-06 | 58 | 40 | 4 | IPR000626 | |
| Domain | PHD | 3.86e-05 | 89 | 40 | 4 | SM00249 | |
| Domain | Znf_PHD | 4.21e-05 | 91 | 40 | 4 | IPR001965 | |
| Domain | ZF_PHD_2 | 4.99e-05 | 95 | 40 | 4 | PS50016 | |
| Domain | ZF_PHD_1 | 5.20e-05 | 96 | 40 | 4 | PS01359 | |
| Domain | UBIQUITIN_1 | 6.72e-05 | 37 | 40 | 3 | PS00299 | |
| Domain | HMG_box | 1.98e-04 | 53 | 40 | 3 | PF00505 | |
| Domain | STI1_HS-bd | 1.99e-04 | 10 | 40 | 2 | IPR006636 | |
| Domain | STI1 | 1.99e-04 | 10 | 40 | 2 | SM00727 | |
| Domain | HMG | 2.09e-04 | 54 | 40 | 3 | SM00398 | |
| Domain | Znf_FYVE_PHD | 2.70e-04 | 147 | 40 | 4 | IPR011011 | |
| Domain | HMG_box_dom | 3.63e-04 | 65 | 40 | 3 | IPR009071 | |
| Domain | PHD | 5.52e-04 | 75 | 40 | 3 | PF00628 | |
| Domain | Ubiquitin-rel_dom | 6.32e-04 | 184 | 40 | 4 | IPR029071 | |
| Domain | Znf_PHD-finger | 6.43e-04 | 79 | 40 | 3 | IPR019787 | |
| Domain | 6-PGluconate_DH_C-like | 7.47e-04 | 19 | 40 | 2 | IPR008927 | |
| Domain | EPHD | 1.01e-03 | 22 | 40 | 2 | PS51805 | |
| Domain | UBA | 1.87e-03 | 30 | 40 | 2 | SM00165 | |
| Domain | UBA | 2.69e-03 | 36 | 40 | 2 | PF00627 | |
| Domain | UBA | 4.00e-03 | 44 | 40 | 2 | IPR015940 | |
| Domain | UBA | 4.55e-03 | 47 | 40 | 2 | PS50030 | |
| Domain | HMG_BOX_2 | 5.97e-03 | 54 | 40 | 2 | PS50118 | |
| Domain | - | 6.18e-03 | 55 | 40 | 2 | 1.10.30.10 | |
| Domain | Ser/Thr_kinase_AS | 6.97e-03 | 357 | 40 | 4 | IPR008271 | |
| Domain | S_TKc | 7.11e-03 | 359 | 40 | 4 | SM00220 | |
| Domain | PROTEIN_KINASE_ST | 7.32e-03 | 362 | 40 | 4 | PS00108 | |
| Domain | UBA-like | 8.29e-03 | 64 | 40 | 2 | IPR009060 | |
| Pathway | WP_PATHWAYS_AFFECTED_IN_ADENOID_CYSTIC_CARCINOMA | 1.52e-05 | 65 | 33 | 4 | M39682 | |
| Pubmed | Interaction network of human early embryonic transcription factors. | 2.04e-10 | 351 | 40 | 9 | 38297188 | |
| Pubmed | SOX6 NFYC UHRF1 ZFHX3 ZBTB33 TCF20 MGA CLOCK KDM5A TLE3 TOX3 | 1.24e-09 | 808 | 40 | 11 | 20412781 | |
| Pubmed | PAXIP1 SOX6 NFYC KMT2C ZFHX3 ZBTB33 TCF20 MGA KDM5A CREBBP USP9X RBM4 TLE3 | 3.84e-09 | 1429 | 40 | 13 | 35140242 | |
| Pubmed | 2.24e-08 | 418 | 40 | 8 | 34709266 | ||
| Pubmed | 9.28e-08 | 503 | 40 | 8 | 16964243 | ||
| Pubmed | 1.19e-07 | 733 | 40 | 9 | 34672954 | ||
| Pubmed | 1.81e-07 | 549 | 40 | 8 | 38280479 | ||
| Pubmed | Identification and functional characterization of transcriptional activators in human cells. | 3.28e-07 | 398 | 40 | 7 | 35016035 | |
| Pubmed | 5.67e-07 | 57 | 40 | 4 | 18022353 | ||
| Pubmed | 6.10e-07 | 268 | 40 | 6 | 33640491 | ||
| Pubmed | The ubiquilin gene family: evolutionary patterns and functional insights. | 1.29e-06 | 2 | 40 | 2 | 24674348 | |
| Pubmed | TWIST1 and chromatin regulatory proteins interact to guide neural crest cell differentiation. | 7.65e-06 | 109 | 40 | 4 | 33554859 | |
| Pubmed | 7.73e-06 | 4 | 40 | 2 | 19703992 | ||
| Pubmed | 7.73e-06 | 4 | 40 | 2 | 26164627 | ||
| Pubmed | CBP/p300 is a cell type-specific modulator of CLOCK/BMAL1-mediated transcription. | 7.73e-06 | 4 | 40 | 2 | 19922678 | |
| Pubmed | 7.73e-06 | 4 | 40 | 2 | 28398509 | ||
| Pubmed | Signaling mediated by the dopamine D2 receptor potentiates circadian regulation by CLOCK:BMAL1. | 7.73e-06 | 4 | 40 | 2 | 16606840 | |
| Pubmed | FOXA1 Directs H3K4 Monomethylation at Enhancers via Recruitment of the Methyltransferase MLL3. | 9.50e-06 | 248 | 40 | 5 | 27926873 | |
| Pubmed | 1.29e-05 | 5 | 40 | 2 | 9990060 | ||
| Pubmed | Cryptochrome 1 regulates the circadian clock through dynamic interactions with the BMAL1 C terminus. | 1.29e-05 | 5 | 40 | 2 | 25961797 | |
| Pubmed | 1.29e-05 | 5 | 40 | 2 | 26744420 | ||
| Pubmed | The protein interaction landscape of the human CMGC kinase group. | 1.30e-05 | 695 | 40 | 7 | 23602568 | |
| Pubmed | Comparative Application of BioID and TurboID for Protein-Proximity Biotinylation. | 1.31e-05 | 457 | 40 | 6 | 32344865 | |
| Pubmed | An organelle-specific protein landscape identifies novel diseases and molecular mechanisms. | 1.51e-05 | 1321 | 40 | 9 | 27173435 | |
| Pubmed | BioID identifies novel c-MYC interacting partners in cultured cells and xenograft tumors. | 1.73e-05 | 134 | 40 | 4 | 25452129 | |
| Pubmed | 1.76e-05 | 282 | 40 | 5 | 23667531 | ||
| Pubmed | Mapping the Ku Interactome Using Proximity-Dependent Biotin Identification in Human Cells. | 1.79e-05 | 283 | 40 | 5 | 30585729 | |
| Pubmed | 1.85e-05 | 486 | 40 | 6 | 20936779 | ||
| Pubmed | 1.93e-05 | 6 | 40 | 2 | 16678094 | ||
| Pubmed | UHRF1 inhibits MDR1 gene transcription and sensitizes breast cancer cells to anticancer drugs. | 1.93e-05 | 6 | 40 | 2 | 20037778 | |
| Pubmed | Coactivation of the CLOCK-BMAL1 complex by CBP mediates resetting of the circadian clock. | 1.93e-05 | 6 | 40 | 2 | 20930143 | |
| Pubmed | Histone lysine demethylase JARID1a activates CLOCK-BMAL1 and influences the circadian clock. | 1.93e-05 | 6 | 40 | 2 | 21960634 | |
| Pubmed | 4.70e-05 | 173 | 40 | 4 | 36217029 | ||
| Pubmed | 5.51e-05 | 591 | 40 | 6 | 15231748 | ||
| Pubmed | 5.77e-05 | 10 | 40 | 2 | 25223786 | ||
| Pubmed | 7.05e-05 | 11 | 40 | 2 | 24349473 | ||
| Pubmed | A census of human transcription factors: function, expression and evolution. | 7.10e-05 | 908 | 40 | 7 | 19274049 | |
| Pubmed | 8.40e-05 | 638 | 40 | 6 | 31182584 | ||
| Pubmed | Histone acetyltransferase-dependent chromatin remodeling and the vascular clock. | 8.45e-05 | 12 | 40 | 2 | 14645221 | |
| Pubmed | Identification of E-box factor TFE3 as a functional partner for the E2F3 transcription factor. | 8.45e-05 | 12 | 40 | 2 | 12748276 | |
| Pubmed | 8.85e-05 | 396 | 40 | 5 | 26687479 | ||
| Pubmed | H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids. | 9.56e-05 | 1294 | 40 | 8 | 30804502 | |
| Pubmed | Demethylation of H3K27 regulates polycomb recruitment and H2A ubiquitination. | 9.98e-05 | 13 | 40 | 2 | 17761849 | |
| Pubmed | 9.98e-05 | 13 | 40 | 2 | 24619213 | ||
| Pubmed | 9.98e-05 | 13 | 40 | 2 | 22735158 | ||
| Pubmed | The ubiquitin ligase TRIM25 targets ERG for degradation in prostate cancer. | 1.16e-04 | 14 | 40 | 2 | 27626314 | |
| Pubmed | 1.16e-04 | 14 | 40 | 2 | 12482968 | ||
| Pubmed | 1.21e-04 | 83 | 40 | 3 | 28794006 | ||
| Pubmed | 1.23e-04 | 222 | 40 | 4 | 37071664 | ||
| Pubmed | 1.34e-04 | 15 | 40 | 2 | 17925232 | ||
| Pubmed | 1.49e-04 | 709 | 40 | 6 | 22988430 | ||
| Pubmed | 1.53e-04 | 16 | 40 | 2 | 24368734 | ||
| Pubmed | 1.73e-04 | 17 | 40 | 2 | 26180087 | ||
| Pubmed | 1.73e-04 | 17 | 40 | 2 | 37080995 | ||
| Pubmed | PTIP associates with MLL3- and MLL4-containing histone H3 lysine 4 methyltransferase complex. | 1.95e-04 | 18 | 40 | 2 | 17500065 | |
| Pubmed | Wnt-Dependent Inactivation of the Groucho/TLE Co-repressor by the HECT E3 Ubiquitin Ligase Hyd/UBR5. | 1.95e-04 | 18 | 40 | 2 | 28689657 | |
| Pubmed | 1.97e-04 | 251 | 40 | 4 | 31076518 | ||
| Pubmed | 2.36e-04 | 1103 | 40 | 7 | 34189442 | ||
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | 2.40e-04 | 774 | 40 | 6 | 15302935 | |
| Pubmed | Resetting the epigenetic balance of Polycomb and COMPASS function at enhancers for cancer therapy. | 2.42e-04 | 20 | 40 | 2 | 29785026 | |
| Pubmed | 2.42e-04 | 20 | 40 | 2 | 19047629 | ||
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | 2.50e-04 | 1489 | 40 | 8 | 28611215 | |
| Pubmed | Differential gene expression in the distal tip endoderm of the embryonic mouse lung. | 2.67e-04 | 21 | 40 | 2 | 12617806 | |
| Pubmed | Broad histone H3K4me3 domains in mouse oocytes modulate maternal-to-zygotic transition. | 2.67e-04 | 21 | 40 | 2 | 27626377 | |
| Pubmed | Heritability and genetic association analysis of cognition in the Diabetes Heart Study. | 2.67e-04 | 21 | 40 | 2 | 24684796 | |
| Pubmed | LASP-1: a nuclear hub for the UHRF1-DNMT1-G9a-Snail1 complex. | 2.94e-04 | 22 | 40 | 2 | 25982273 | |
| Pubmed | Structural basis for activity regulation of MLL family methyltransferases. | 2.94e-04 | 22 | 40 | 2 | 26886794 | |
| Pubmed | Endogenous purification reveals GREB1 as a key estrogen receptor regulatory factor. | 3.02e-04 | 113 | 40 | 3 | 23403292 | |
| Pubmed | 3.21e-04 | 23 | 40 | 2 | 9225980 | ||
| Pubmed | 4.12e-04 | 26 | 40 | 2 | 28720576 | ||
| Pubmed | Proteomic analyses reveal distinct chromatin-associated and soluble transcription factor complexes. | 4.13e-04 | 857 | 40 | 6 | 25609649 | |
| Pubmed | An atlas of combinatorial transcriptional regulation in mouse and man. | 4.67e-04 | 877 | 40 | 6 | 20211142 | |
| Pubmed | Interactome of vertebrate GAF/ThPOK reveals its diverse functions in gene regulation and DNA repair. | 5.01e-04 | 321 | 40 | 4 | 32098917 | |
| Pubmed | Immunoaffinity profiling of tyrosine phosphorylation in cancer cells. | 5.37e-04 | 327 | 40 | 4 | 15592455 | |
| Pubmed | Identification and characterization of a novel human PP1 phosphatase complex. | 5.87e-04 | 31 | 40 | 2 | 20516061 | |
| Pubmed | 5.88e-04 | 335 | 40 | 4 | 15741177 | ||
| Pubmed | Gfi1b regulates the level of Wnt/β-catenin signaling in hematopoietic stem cells and megakaryocytes. | 7.07e-04 | 34 | 40 | 2 | 30894540 | |
| Pubmed | 7.18e-04 | 152 | 40 | 3 | 38360978 | ||
| Pubmed | WW domains provide a platform for the assembly of multiprotein networks. | 7.46e-04 | 154 | 40 | 3 | 16055720 | |
| Pubmed | Ubiquitin-Independent Disassembly by a p97 AAA-ATPase Complex Drives PP1 Holoenzyme Formation. | 7.77e-04 | 361 | 40 | 4 | 30344098 | |
| Pubmed | 7.89e-04 | 157 | 40 | 3 | 30186101 | ||
| Pubmed | Noncanonical regulation of alkylation damage resistance by the OTUD4 deubiquitinase. | 9.30e-04 | 39 | 40 | 2 | 25944111 | |
| Pubmed | An Oct4-centered protein interaction network in embryonic stem cells. | 9.43e-04 | 167 | 40 | 3 | 20362541 | |
| Pubmed | Identification and Functional Characterization of a Novel Androgen Receptor Coregulator, EAP1. | 9.79e-04 | 40 | 40 | 2 | 34585037 | |
| Pubmed | Transcriptional Networks Controlled by NKX2-1 in the Development of Forebrain GABAergic Neurons. | 9.79e-04 | 40 | 40 | 2 | 27657450 | |
| Pubmed | A neurogenomics approach to gene expression analysis in the developing brain. | 9.93e-04 | 170 | 40 | 3 | 15582152 | |
| Pubmed | A trimeric Rab7 GEF controls NPC1-dependent lysosomal cholesterol export. | 1.05e-03 | 392 | 40 | 4 | 33144569 | |
| Pubmed | 1.08e-03 | 42 | 40 | 2 | 18985028 | ||
| Pubmed | 1.09e-03 | 686 | 40 | 5 | 28380382 | ||
| Pubmed | 1.12e-03 | 689 | 40 | 5 | 36543142 | ||
| Pubmed | A deep proteomics perspective on CRM1-mediated nuclear export and nucleocytoplasmic partitioning. | 1.12e-03 | 1038 | 40 | 6 | 26673895 | |
| Pubmed | Identification of Novel Nuclear Factor of Activated T Cell (NFAT)-associated Proteins in T Cells. | 1.13e-03 | 178 | 40 | 3 | 27637333 | |
| Interaction | ERG interactions | 1.12e-08 | 223 | 40 | 8 | int:ERG | |
| Interaction | KDM1A interactions | SOX6 UHRF1 ZFHX3 ZBTB33 TCF20 MGA CLOCK KDM5A USP9X GOLGA2 TLE3 DENND4C BUB1 | 1.72e-08 | 941 | 40 | 13 | int:KDM1A |
| Interaction | CRX interactions | 3.10e-08 | 254 | 40 | 8 | int:CRX | |
| Interaction | TLE3 interactions | 4.09e-08 | 376 | 40 | 9 | int:TLE3 | |
| Interaction | EGR2 interactions | 4.12e-08 | 171 | 40 | 7 | int:EGR2 | |
| Interaction | HNF1B interactions | 8.49e-08 | 190 | 40 | 7 | int:HNF1B | |
| Interaction | HDAC1 interactions | SOX6 NFYC UHRF1 ZFHX3 ZBTB33 TCF20 MGA KDM5A CREBBP TLE3 DENND4C SHCBP1 BUB1 | 1.17e-07 | 1108 | 40 | 13 | int:HDAC1 |
| Interaction | FEV interactions | 1.33e-07 | 203 | 40 | 7 | int:FEV | |
| Interaction | PAX6 interactions | 5.08e-07 | 366 | 40 | 8 | int:PAX6 | |
| Interaction | SOX7 interactions | 5.80e-07 | 82 | 40 | 5 | int:SOX7 | |
| Interaction | KDM6A interactions | 7.53e-07 | 162 | 40 | 6 | int:KDM6A | |
| Interaction | GSC interactions | 7.80e-07 | 87 | 40 | 5 | int:GSC | |
| Interaction | KMT2D interactions | 9.64e-07 | 169 | 40 | 6 | int:KMT2D | |
| Interaction | TLX1 interactions | 1.18e-06 | 175 | 40 | 6 | int:TLX1 | |
| Interaction | TEAD1 interactions | 1.22e-06 | 176 | 40 | 6 | int:TEAD1 | |
| Interaction | SP7 interactions | 2.02e-06 | 304 | 40 | 7 | int:SP7 | |
| Interaction | GATA2 interactions | 2.49e-06 | 199 | 40 | 6 | int:GATA2 | |
| Interaction | KMT2A interactions | 2.50e-06 | 314 | 40 | 7 | int:KMT2A | |
| Interaction | TBXT interactions | 3.25e-06 | 116 | 40 | 5 | int:TBXT | |
| Interaction | PAX7 interactions | 4.50e-06 | 124 | 40 | 5 | int:PAX7 | |
| Interaction | CDK8 interactions | 4.69e-06 | 222 | 40 | 6 | int:CDK8 | |
| Interaction | RCOR1 interactions | 4.75e-06 | 494 | 40 | 8 | int:RCOR1 | |
| Interaction | CIC interactions | 5.29e-06 | 673 | 40 | 9 | int:CIC | |
| Interaction | NFIX interactions | 5.33e-06 | 227 | 40 | 6 | int:NFIX | |
| Interaction | PAX9 interactions | 5.68e-06 | 130 | 40 | 5 | int:PAX9 | |
| Interaction | MYB interactions | 6.35e-06 | 133 | 40 | 5 | int:MYB | |
| Interaction | NFIB interactions | 8.73e-06 | 142 | 40 | 5 | int:NFIB | |
| Interaction | TLX2 interactions | 8.73e-06 | 142 | 40 | 5 | int:TLX2 | |
| Interaction | GCM1 interactions | 9.89e-06 | 68 | 40 | 4 | int:GCM1 | |
| Interaction | SOX6 interactions | 1.42e-05 | 157 | 40 | 5 | int:SOX6 | |
| Interaction | LHX4 interactions | 1.86e-05 | 166 | 40 | 5 | int:LHX4 | |
| Interaction | PAX2 interactions | 2.40e-05 | 85 | 40 | 4 | int:PAX2 | |
| Interaction | LHX3 interactions | 3.13e-05 | 185 | 40 | 5 | int:LHX3 | |
| Interaction | HIVEP1 interactions | 3.21e-05 | 186 | 40 | 5 | int:HIVEP1 | |
| Interaction | FOXI1 interactions | 3.28e-05 | 92 | 40 | 4 | int:FOXI1 | |
| Interaction | NFIA interactions | 3.38e-05 | 188 | 40 | 5 | int:NFIA | |
| Interaction | MYOD1 interactions | 3.93e-05 | 194 | 40 | 5 | int:MYOD1 | |
| Interaction | NANOG interactions | 3.98e-05 | 481 | 40 | 7 | int:NANOG | |
| Interaction | KLF5 interactions | 4.03e-05 | 195 | 40 | 5 | int:KLF5 | |
| Interaction | SOX9 interactions | 4.03e-05 | 97 | 40 | 4 | int:SOX9 | |
| Interaction | YAP1 interactions | UHRF1 KMT2C ZBTB33 UBQLN1 TCF20 MGA CREBBP CDK12 USP9X AMOTL1 | 4.09e-05 | 1095 | 40 | 10 | int:YAP1 |
| Interaction | H3C1 interactions | 5.36e-05 | 901 | 40 | 9 | int:H3C1 | |
| Interaction | PHF21A interactions | 5.48e-05 | 343 | 40 | 6 | int:PHF21A | |
| Interaction | NFIC interactions | 5.73e-05 | 210 | 40 | 5 | int:NFIC | |
| Interaction | EP300 interactions | PAXIP1 ZBTB33 UBQLN1 CLOCK CREBBP CDK12 USP9X RBM4 GOLGA2 TLE3 GABPB1 | 6.22e-05 | 1401 | 40 | 11 | int:EP300 |
| Interaction | ZFHX3 interactions | 6.37e-05 | 109 | 40 | 4 | int:ZFHX3 | |
| Interaction | EN1 interactions | 6.60e-05 | 110 | 40 | 4 | int:EN1 | |
| Interaction | XRCC6 interactions | 6.74e-05 | 928 | 40 | 9 | int:XRCC6 | |
| Interaction | PAX8 interactions | 6.84e-05 | 111 | 40 | 4 | int:PAX8 | |
| Interaction | SOX2 interactions | PAXIP1 SOX6 KMT2C ZFHX3 TCF20 CLOCK CDK12 USP9X RBM4 TLE3 SHCBP1 | 7.12e-05 | 1422 | 40 | 11 | int:SOX2 |
| Interaction | TFF1 interactions | 7.33e-05 | 41 | 40 | 3 | int:TFF1 | |
| Interaction | TBR1 interactions | 7.33e-05 | 113 | 40 | 4 | int:TBR1 | |
| Interaction | NCOR1 interactions | 7.50e-05 | 363 | 40 | 6 | int:NCOR1 | |
| Interaction | ETS1 interactions | 9.56e-05 | 121 | 40 | 4 | int:ETS1 | |
| Interaction | AR interactions | 1.12e-04 | 992 | 40 | 9 | int:AR | |
| Interaction | SMAD1 interactions | 1.14e-04 | 243 | 40 | 5 | int:SMAD1 | |
| Interaction | PYGO2 interactions | 1.18e-04 | 48 | 40 | 3 | int:PYGO2 | |
| Interaction | POU5F1 interactions | 1.34e-04 | 584 | 40 | 7 | int:POU5F1 | |
| Interaction | RSPH14 interactions | 1.50e-04 | 52 | 40 | 3 | int:RSPH14 | |
| Interaction | DYNLL2 interactions | 1.65e-04 | 263 | 40 | 5 | int:DYNLL2 | |
| Interaction | WWTR1 interactions | 1.71e-04 | 422 | 40 | 6 | int:WWTR1 | |
| Interaction | NCOA2 interactions | 1.73e-04 | 141 | 40 | 4 | int:NCOA2 | |
| Interaction | MED23 interactions | 1.74e-04 | 266 | 40 | 5 | int:MED23 | |
| Interaction | NUP35 interactions | 1.75e-04 | 424 | 40 | 6 | int:NUP35 | |
| Interaction | TPRX2 interactions | 1.87e-04 | 56 | 40 | 3 | int:TPRX2 | |
| Interaction | NCOA6 interactions | 1.92e-04 | 145 | 40 | 4 | int:NCOA6 | |
| Interaction | TCF20 interactions | 1.97e-04 | 146 | 40 | 4 | int:TCF20 | |
| Interaction | POM121 interactions | 2.02e-04 | 147 | 40 | 4 | int:POM121 | |
| Interaction | SIX6 interactions | 2.09e-04 | 11 | 40 | 2 | int:SIX6 | |
| Interaction | H3-4 interactions | 2.36e-04 | 448 | 40 | 6 | int:H3-4 | |
| Interaction | ALKBH3 interactions | 2.41e-04 | 61 | 40 | 3 | int:ALKBH3 | |
| Interaction | SELENOV interactions | 2.50e-04 | 12 | 40 | 2 | int:SELENOV | |
| Interaction | TLX3 interactions | 2.64e-04 | 291 | 40 | 5 | int:TLX3 | |
| Interaction | KLF4 interactions | 2.80e-04 | 160 | 40 | 4 | int:KLF4 | |
| Interaction | UBL7 interactions | 3.18e-04 | 67 | 40 | 3 | int:UBL7 | |
| Interaction | RBM11 interactions | 3.45e-04 | 169 | 40 | 4 | int:RBM11 | |
| Interaction | TWIST1 interactions | 3.52e-04 | 170 | 40 | 4 | int:TWIST1 | |
| Interaction | SETD1A interactions | 3.52e-04 | 170 | 40 | 4 | int:SETD1A | |
| Interaction | GATA1 interactions | 3.60e-04 | 171 | 40 | 4 | int:GATA1 | |
| Interaction | MAML1 interactions | 4.09e-04 | 73 | 40 | 3 | int:MAML1 | |
| Interaction | TDP2 interactions | 4.26e-04 | 74 | 40 | 3 | int:TDP2 | |
| Interaction | TSHZ3 interactions | 4.26e-04 | 74 | 40 | 3 | int:TSHZ3 | |
| Interaction | PIAS2 interactions | 4.38e-04 | 180 | 40 | 4 | int:PIAS2 | |
| Interaction | RNF6 interactions | 4.61e-04 | 76 | 40 | 3 | int:RNF6 | |
| Interaction | LHX2 interactions | 4.66e-04 | 183 | 40 | 4 | int:LHX2 | |
| Interaction | GATA3 interactions | 5.05e-04 | 187 | 40 | 4 | int:GATA3 | |
| Interaction | ZAR1L interactions | 5.13e-04 | 17 | 40 | 2 | int:ZAR1L | |
| Interaction | GOLGA2 interactions | 5.35e-04 | 733 | 40 | 7 | int:GOLGA2 | |
| Interaction | HNF1A interactions | 5.35e-04 | 80 | 40 | 3 | int:HNF1A | |
| Interaction | NR3C1 interactions | 5.59e-04 | 974 | 40 | 8 | int:NR3C1 | |
| Interaction | ARL16 interactions | 5.96e-04 | 83 | 40 | 3 | int:ARL16 | |
| Interaction | FOXL1 interactions | 6.03e-04 | 196 | 40 | 4 | int:FOXL1 | |
| Interaction | ARID4B interactions | 6.38e-04 | 199 | 40 | 4 | int:ARID4B | |
| Interaction | IRF4 interactions | 6.39e-04 | 85 | 40 | 3 | int:IRF4 | |
| Interaction | KANSL3 interactions | 6.61e-04 | 86 | 40 | 3 | int:KANSL3 | |
| Interaction | RING1 interactions | 6.63e-04 | 201 | 40 | 4 | int:RING1 | |
| Interaction | KAT5 interactions | 6.79e-04 | 358 | 40 | 5 | int:KAT5 | |
| Interaction | CDH1 interactions | 7.06e-04 | 768 | 40 | 7 | int:CDH1 | |
| Interaction | RAI2 interactions | 7.14e-04 | 20 | 40 | 2 | int:RAI2 | |
| Interaction | SIX3 interactions | 7.14e-04 | 20 | 40 | 2 | int:SIX3 | |
| GeneFamily | Ubiquilin family | 3.32e-08 | 5 | 28 | 3 | 783 | |
| GeneFamily | Zinc fingers ZZ-type|Lysine acetyltransferases | 3.10e-04 | 17 | 28 | 2 | 486 | |
| GeneFamily | PHD finger proteins | 3.57e-04 | 90 | 28 | 3 | 88 | |
| GeneFamily | Ataxins|Trinucleotide repeat containing | 6.79e-04 | 25 | 28 | 2 | 775 | |
| Coexpression | KIM_PTEN_TARGETS_DN | 2.26e-05 | 5 | 40 | 2 | M2277 | |
| Coexpression | CUI_TCF21_TARGETS_2_DN | 3.75e-05 | 854 | 40 | 8 | M1533 | |
| Coexpression | CUI_TCF21_TARGETS_2_DN | 4.94e-05 | 888 | 40 | 8 | MM1018 | |
| ToppCell | 390C-Lymphocytic-NK_cells-Proliferating_NK_cell|NK_cells / Donor, Lineage, Cell class and subclass (all cells) | 5.54e-07 | 179 | 40 | 5 | e67ad7ab04d0c1309296f57c1f53c5ca14c213fe | |
| ToppCell | TCGA-Prostate-Primary_Tumor-Prostate_Adenocarcinoma-Acinar_Adenocarcinoma-6|TCGA-Prostate / Sample_Type by Project: Shred V9 | 8.03e-07 | 193 | 40 | 5 | abd71b2cf667ef2b1c4d88acd0c1dd19a12ff659 | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Pvalb-Pvalb_Reln_Itm2a|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 8.41e-06 | 144 | 40 | 4 | 0bbe670454846cf9bc7464ae4e91488415c4111d | |
| ToppCell | droplet-Skin-nan-18m-Epithelial-stem_cell_of_epidermis|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.44e-05 | 165 | 40 | 4 | 96f0d8bc9b13e23f757e6bb98cd7dc061a8a9564 | |
| ToppCell | 10x_5'_v1-Neoplastic-Stem-like-OPC-like|10x_5'_v1 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.81e-05 | 175 | 40 | 4 | cc596907ea1a64ab7b5a8c7d4ad12e6ee59bfed9 | |
| ToppCell | 10x_5'_v1-Neoplastic-Stem-like|10x_5'_v1 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.81e-05 | 175 | 40 | 4 | a8400e7e47379901dcab5f2e364c3ff17765b4b9 | |
| ToppCell | 10x_5'_v1-Neoplastic-Stem-like-OPC-like-OPC-like|10x_5'_v1 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.81e-05 | 175 | 40 | 4 | 8a3abf40146ae3459d97cdf865c1c8f6b92ac639 | |
| ToppCell | 10x_5'_v1-Neoplastic-Stem-like-OPC-like-OPC-like-Z|10x_5'_v1 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.81e-05 | 175 | 40 | 4 | 378d2b79edac91fc74eee0fb42bb29dd9b07c36f | |
| ToppCell | 390C-Lymphocytic-NK_cells-Proliferating_NK_cell|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 1.85e-05 | 176 | 40 | 4 | 8813c01ea080f373fe3970c5e1ba4c2dca0f7f02 | |
| ToppCell | facs-Pancreas-Exocrine-3m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.94e-05 | 178 | 40 | 4 | fcbbcc44271515de1969b4732b6441c012693d5f | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L3-4_PVALB_HOMER3|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.07e-05 | 181 | 40 | 4 | bd7e9437839bca543ca5945df43d6525e6a312a8 | |
| ToppCell | COVID-19-B_cells-Plasma_cells|COVID-19 / group, cell type (main and fine annotations) | 2.16e-05 | 183 | 40 | 4 | 130c109f63a5e3c8f83cb96e32f4addf513b6415 | |
| ToppCell | COVID-19-B_cells|COVID-19 / group, cell type (main and fine annotations) | 2.16e-05 | 183 | 40 | 4 | 2c016bb59f131a0e821853b085289a3583f0a729 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L2-4_PVALB_C8orf4|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.16e-05 | 183 | 40 | 4 | 04d3cc76038b8192c915f1c08c3e26f2ad3b3779 | |
| ToppCell | droplet-Limb_Muscle-nan-3m-Macroglial-nan|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.25e-05 | 185 | 40 | 4 | 554c5d812197fbf66bf279fcc953277e926ade15 | |
| ToppCell | pdx|World / Sample and Cell Type and Tumor Cluster (all cells) | 2.30e-05 | 186 | 40 | 4 | de8e538c8767d41b8a52f5e58ba1affd4e7244c4 | |
| ToppCell | pdx-Tumor_cells|World / Sample and Cell Type and Tumor Cluster (all cells) | 2.30e-05 | 186 | 40 | 4 | 0b88a87158a9ca8de3bf40a4ff1687150707a5f0 | |
| ToppCell | 3'_v3-GI_small-bowel-Lymphocytic_NK-Cycling_NK|GI_small-bowel / Manually curated celltypes from each tissue | 2.35e-05 | 187 | 40 | 4 | 265c690c2921fd201361a0ec8bc4d2a996fbcaf4 | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum-3m-Epithelial|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.35e-05 | 187 | 40 | 4 | 4d12c70c8ed922fbc8f7b139145611203735cab4 | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum-3m-Epithelial-nan|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.35e-05 | 187 | 40 | 4 | e851ee46a6b4068a7bd7602ee183c0ace50ee4dd | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum-3m-Epithelial-neuronal_stem_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.35e-05 | 187 | 40 | 4 | e46b49b4053d2d0f3e1d2bcdc380f7f8733cbe07 | |
| ToppCell | COVID-19-lung-Plasma_cells_PRDM1/BLIMP_hi|COVID-19 / Disease (COVID-19 only), tissue and cell type | 2.40e-05 | 188 | 40 | 4 | 567b08514d9d84cbb40f9b7a679eec304f023428 | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.50e-05 | 190 | 40 | 4 | 3f22c118d552345f731d4d49f0bcb5765d93de3b | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.50e-05 | 190 | 40 | 4 | 305fbef734c350cfbf786ca7ff6e07093aab56ea | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L2-4_PVALB_C8orf4|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.50e-05 | 190 | 40 | 4 | 39ab890104b4264c68a968f920f4ccd84f0bc681 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L2-4_PVALB_C8orf4|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.50e-05 | 190 | 40 | 4 | 0acf1d5da68db449d8c9e70519a236ce825f9d11 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_ascending_limb_epithelial_cell-Ascending_Thin_Limb_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.50e-05 | 190 | 40 | 4 | 59bbbd2c8d4b7ce46c54ca8022b1557e7e5eee2a | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L2-4_PVALB_C8orf4|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.50e-05 | 190 | 40 | 4 | e58e4b6fbeb4368f738adac67ec10879c0966f0f | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_SST-Inh_L2-4_SST_AHR|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.55e-05 | 191 | 40 | 4 | 782bc7946417549ffd39e5b596db659436fa01ba | |
| ToppCell | facs-Pancreas-Endocrine-3m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.60e-05 | 192 | 40 | 4 | 5b7093d5af5ae7b0e6d3a464cc56272440ecedad | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_3|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.66e-05 | 193 | 40 | 4 | 53bcd50892c379b2a571751f6eb1062436339fe7 | |
| ToppCell | TCGA-Endometrium-Primary_Tumor-Endometrial_Adenocarcinoma-Endometrioid-1|TCGA-Endometrium / Sample_Type by Project: Shred V9 | 2.66e-05 | 193 | 40 | 4 | c2673d86f7d7b849788036032a93a6d136a70040 | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_SST|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.66e-05 | 193 | 40 | 4 | d1445b8bf2bab36e1a326ddb2a528151db016c7d | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_3|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.66e-05 | 193 | 40 | 4 | 4979862c0c16e6b4baa4c79894f1d237c861f5a5 | |
| ToppCell | facs-Marrow-B-cells-18m-Lymphocytic-late_pro-B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.66e-05 | 193 | 40 | 4 | 9c2f58b4c89dc084a1a6e53952ea793e87a96660 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_SST|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.66e-05 | 193 | 40 | 4 | 3ed46f5a7419ec4eddbd0df0d9b5f53aa486198b | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.66e-05 | 193 | 40 | 4 | c4b22b62f3cc7bf0ec0eba76e1504c236290bbc9 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_SST|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.66e-05 | 193 | 40 | 4 | 2189da4b727e25e62669d7b9257f06493be21a27 | |
| ToppCell | facs-Marrow-B-cells-18m-Lymphocytic-late_pro_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.66e-05 | 193 | 40 | 4 | db881cc129b45031fd84d052768cef53508de196 | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_SST-Inh_L3-5_SST_MAFB|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.66e-05 | 193 | 40 | 4 | e74fdc8718fe0933e1f4dd3fe37e2134983b99b6 | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_3|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.71e-05 | 194 | 40 | 4 | e5990880961d2469759ce4b3b20ae93ace3ebd1f | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.71e-05 | 194 | 40 | 4 | 4f758718a1233c25c25d99fc1b7b06f906b8b0a2 | |
| ToppCell | facs-Thymus-nan-3m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.77e-05 | 195 | 40 | 4 | 93c345e70d6c8ff5d12fd63d73228c1700b804a0 | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.82e-05 | 196 | 40 | 4 | 7af6c5147ac859353504d19727dbe24f63a29dd4 | |
| ToppCell | Lung_Parenchyma-Control-Lymphocyte-B-Plasmablast-Plasmablast-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.88e-05 | 197 | 40 | 4 | 0d38d126b1e653398426255e95449f1150eac1b0 | |
| ToppCell | Parenchyma_Control_(B.)-Immune-TX-Plasma_cells|Parenchyma_Control_(B.) / Sample group, Lineage and Cell type | 2.88e-05 | 197 | 40 | 4 | 7ffb373d5b72c67e4816f14ea9a7a2024dc7a93a | |
| ToppCell | Lung_Parenchyma-Control-Lymphocyte-B-Plasmablast|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 2.88e-05 | 197 | 40 | 4 | 2e76e9ebd8702bfeefd396cbf5114eee0f24c19b | |
| ToppCell | Lung_Parenchyma-Control-Lymphocyte-B-Plasmablast-Plasmablast|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 2.88e-05 | 197 | 40 | 4 | 207fce47e547fafbaf64a22efe3488e74bf19bed | |
| ToppCell | Tracheal-10x3prime_v2-Epithelial-Epi_airway_basal-Dividing_Basal|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 2.88e-05 | 197 | 40 | 4 | 0a6754a5109bec0d0de42adbfdf4db43ff60c3d2 | |
| ToppCell | mild-Plasmablast|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 2.88e-05 | 197 | 40 | 4 | 21085d5e27b5a23a241a933058bb89f8a1fcf198 | |
| ToppCell | LPS_only-Endothelial-Endothelial-FOXM1|LPS_only / Treatment groups by lineage, cell group, cell type | 2.88e-05 | 197 | 40 | 4 | 038fd92750257d43d5e980fd06d77742b543f11a | |
| ToppCell | Control-Control-Lymphocyte-B-Plasmablast|Control / Disease, condition lineage and cell class | 3.00e-05 | 199 | 40 | 4 | c11aa8bca3723a886e7082ae48bb922dd8396be4 | |
| ToppCell | (5)_Dendritic_cell-(52)_cycling_DCs|(5)_Dendritic_cell / shred on Cell_type and subtype | 3.00e-05 | 199 | 40 | 4 | d0ff446a197062b10f37b585f3f8716d6d89e5b7 | |
| ToppCell | Brain_organoid-organoid_Paulsen_bioRxiv-3.5_mon-Proliferating-Cycling_IN_Progenitors|3.5_mon / Sample Type, Dataset, Time_group, and Cell type. | 3.00e-05 | 199 | 40 | 4 | f315ec3fb6c0799668c9195f836a77fc0db2b615 | |
| ToppCell | Biopsy_Control_(H.)-Epithelial-Proliferating_Epithelial_cells|Biopsy_Control_(H.) / Sample group, Lineage and Cell type | 3.00e-05 | 199 | 40 | 4 | 4fcf5bec207e4384fd73c5e8801a7e414e3ee7b0 | |
| ToppCell | Neuronal-Inhibitory-iB-iB_3(PVALB-SST)-FRZB|Neuronal / cells hierarchy compared to all cells using T-Statistic | 3.05e-05 | 200 | 40 | 4 | e79d93d55b25804f2608185168da472301b6ebca | |
| ToppCell | Neuronal-Inhibitory-iB-iB_2(PVALB)|Neuronal / cells hierarchy compared to all cells using T-Statistic | 3.05e-05 | 200 | 40 | 4 | 1276bfa911fddada4235e12e3081baa53164574b | |
| ToppCell | Transverse-(5)_Dendritic_cell-(52)_cycling_DCs|Transverse / shred on region, Cell_type, and subtype | 3.05e-05 | 200 | 40 | 4 | 51e643d48b5e97a0e117b578a6ea7d429c6cdd1e | |
| ToppCell | Neuronal-Inhibitory-iB-iB_3(PVALB-SST)-FRZB--L2-4|Neuronal / cells hierarchy compared to all cells using T-Statistic | 3.05e-05 | 200 | 40 | 4 | 5ec469267747dce3601c1d8ad01af89fa5b29acc | |
| ToppCell | Neuronal-Inhibitory-iB-iB_2(PVALB)-WFDC2--L2-4|Neuronal / cells hierarchy compared to all cells using T-Statistic | 3.05e-05 | 200 | 40 | 4 | c65e6336725856c4b5f6aeba1cf86a23ec815d34 | |
| ToppCell | Neuronal-Inhibitory-iB-iB_2(PVALB)-WFDC2-|Neuronal / cells hierarchy compared to all cells using T-Statistic | 3.05e-05 | 200 | 40 | 4 | 117a25b3b9cdbc2e198381350a8362bee25e82e7 | |
| ToppCell | Transverse-Dendritic_cell-cycling_DCs|Transverse / Region, Cell class and subclass | 3.05e-05 | 200 | 40 | 4 | f588d8889f351c797963616a3575fa43efd46b9a | |
| ToppCell | Neuronal-Inhibitory-iB|Neuronal / cells hierarchy compared to all cells using T-Statistic | 3.05e-05 | 200 | 40 | 4 | 45ddc5ef2caa87ada88327b63ba9b150a6bb3aa5 | |
| ToppCell | Neuronal-Inhibitory-iB-iB_2(PVALB)-WFDC2|Neuronal / cells hierarchy compared to all cells using T-Statistic | 3.05e-05 | 200 | 40 | 4 | d459e51507bf26865e6e7e04411379ec82a3edf8 | |
| ToppCell | Neuronal-Inhibitory-iB-iB_3(PVALB-SST)-FRZB-|Neuronal / cells hierarchy compared to all cells using T-Statistic | 3.05e-05 | 200 | 40 | 4 | 320d5a3a1e7da2fa8f1a164e29e180ec8ac9889c | |
| ToppCell | (52)_cycling_DCs|World / shred on Cell_type and subtype | 3.11e-05 | 201 | 40 | 4 | ad2d25d84345fdd593065516a05c5c2b5429eac0 | |
| ToppCell | control-Myeloid-Monocyte-derived_DC|Myeloid / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 1.25e-04 | 108 | 40 | 3 | e74e73d89d78c8d59dfdd2bd30db54b366a49d23 | |
| ToppCell | frontal_cortex-Neuronal-GABAergic_neuron-Sst-Sst_Hpse_Cbln4|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.50e-04 | 115 | 40 | 3 | ac73aa06e617ed791c6ae9e38189bac74188c27b | |
| ToppCell | Hippocampus-Macroglia-POLYDENDROCYTE-P5-P5_1-Sox4-POLYDENDROCYTE_(Neurogenesis.Sox4.Hist1h2al)|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 1.96e-04 | 126 | 40 | 3 | 6072996987f7b05949adb86c9433e3302c4441d2 | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Sst-Sst_Hpse_Cbln4|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.96e-04 | 126 | 40 | 3 | 94bd9cfe982b41a3114885173eab55feb0fbbbae | |
| ToppCell | NS-control-d_0-4-Myeloid-Monocyte-derived_DC|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 2.01e-04 | 127 | 40 | 3 | 1f9039d2a9e418c41716c3608d4d03574b71904a | |
| ToppCell | control-Myeloid-Monocyte-derived_DC|control / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 2.06e-04 | 128 | 40 | 3 | 4a1f7b76b64df06531db79e427eda084374ce7b5 | |
| ToppCell | E18.5-samps-Mesenchymal-Matrix_fibroblast-matrix_-_immature_4|E18.5-samps / Age Group, Lineage, Cell class and subclass | 2.15e-04 | 130 | 40 | 3 | 169d88bffd7cd813a484d809defa638ceaca4bcb | |
| ToppCell | frontal_cortex-Neuronal-GABAergic_neuron-Pvalb-Pvalb_Calb1_Sst|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 2.35e-04 | 134 | 40 | 3 | b5466759285b4973850afb2e1be7c1d25f1c7927 | |
| ToppCell | Frontal_cortex-Macroglia-POLYDENDROCYTE-P4-Tnr|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 2.79e-04 | 142 | 40 | 3 | 7bd05d0c0ac2dee0e6cc0f3c531f9154bf300c75 | |
| ToppCell | Frontal_cortex-Macroglia-POLYDENDROCYTE-P4-Tnr-Polydendrocyte.Tnr.Dlx1_(Dlx1)|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 2.79e-04 | 142 | 40 | 3 | 92bf826827b3e3387ad326566556fc90c5c2f4d5 | |
| ToppCell | Frontal_cortex-Macroglia-POLYDENDROCYTE-P4|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 2.79e-04 | 142 | 40 | 3 | 328d08ba2712cd42bb9846ac4d7453ae165b75e2 | |
| ToppCell | Frontal_cortex-Macroglia-POLYDENDROCYTE-P4-Tnr-Polydendrocyte.Tnr.Dlx1_(Dlx1)-|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 2.79e-04 | 142 | 40 | 3 | 94774d3e598d074f48146b0b094705dc48af5a1f | |
| ToppCell | Hippocampus-Macroglia-POLYDENDROCYTE-P5-P5_1|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 3.15e-04 | 148 | 40 | 3 | b9d3421c2eb8e748e9508c1cbd1cb4f96e23db5a | |
| ToppCell | Hippocampus-Macroglia-POLYDENDROCYTE-P5-P5_1-Sox4|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 3.15e-04 | 148 | 40 | 3 | 2a7671dc27afbdf6a92d976c5f2b728bd18dd609 | |
| ToppCell | E16.5-samps|World / Age Group, Lineage, Cell class and subclass | 3.21e-04 | 149 | 40 | 3 | e94d075f68c1c70c89fab50b1b765b5dda650d09 | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW10-OPC_related-Oligodendrocyte/OPC|GW10 / Sample Type, Dataset, Time_group, and Cell type. | 3.34e-04 | 151 | 40 | 3 | 4533bccc996395f74b16af939ce79b6fe253c073 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Outer_Medullary_Collecting_Duct_Principal_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.34e-04 | 151 | 40 | 3 | 10da94037225a71844281ddcb395072250a78094 | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW10-OPC_related|GW10 / Sample Type, Dataset, Time_group, and Cell type. | 3.34e-04 | 151 | 40 | 3 | edb2f59789c295838d2030b80c792cbea25eaa3d | |
| ToppCell | Posterior_cortex-Macroglia-POLYDENDROCYTE-P4-Tnr-Polydendrocyte.Tnr.Dlx1_(Dlx1)-|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 3.47e-04 | 153 | 40 | 3 | d7635f3d4831c02a94f53afc674847d5b51453be | |
| ToppCell | Posterior_cortex-Macroglia-POLYDENDROCYTE-P4-Tnr-Polydendrocyte.Tnr.Dlx1_(Dlx1)|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 3.47e-04 | 153 | 40 | 3 | e50d20f9e553b8c3e10e187770d8abe1a43d109e | |
| ToppCell | Posterior_cortex-Macroglia-POLYDENDROCYTE-P4-Tnr|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 3.47e-04 | 153 | 40 | 3 | 54a941950bbb848077c7bd5726da9e4b3244bd38 | |
| ToppCell | Posterior_cortex-Macroglia-POLYDENDROCYTE-P4|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 3.47e-04 | 153 | 40 | 3 | 69a8550418ba0fc908a84b3b85761abb6e8ca4c0 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Immune-Lymphocytic_B-Plasma_Cell-|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 3.82e-04 | 158 | 40 | 3 | 6b51e5ee08e23924f5edbaf0a845a9232fb7ff7a | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Immune-Lymphocytic_B-Plasma_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 3.82e-04 | 158 | 40 | 3 | 8dd83a2a4c2ec9cdc3a03df8b51ee22bee1c2888 | |
| ToppCell | saliva-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c03-GZMK|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 3.96e-04 | 160 | 40 | 3 | 8e2b51d7b42e0b6e62641efdbbc73d31561d6a3e | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Sst-Sst_Chrna2_Glra3|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 3.96e-04 | 160 | 40 | 3 | 0bfdaf979e6f128cba2928ce16bca4d3deff8ac9 | |
| ToppCell | Globus_pallidus-Macroglia-POLYDENDROCYTE-P5-P5_1|Globus_pallidus / BrainAtlas - Mouse McCarroll V32 | 4.03e-04 | 161 | 40 | 3 | 0dd1401b4c990d49fccb702a9f9867590a58e203 | |
| ToppCell | Globus_pallidus-Macroglia-POLYDENDROCYTE-P5-P5_1-Mitotic.MkI67_(Mitotic.MkI67)-|Globus_pallidus / BrainAtlas - Mouse McCarroll V32 | 4.03e-04 | 161 | 40 | 3 | b6a31c033edc74f23a20aab1f18e80cc83ffee4c | |
| ToppCell | Globus_pallidus-Macroglia-POLYDENDROCYTE-P5|Globus_pallidus / BrainAtlas - Mouse McCarroll V32 | 4.03e-04 | 161 | 40 | 3 | efb811dda4d73107983a5f68302bdcf4f408d5b4 | |
| ToppCell | Globus_pallidus-Macroglia-POLYDENDROCYTE-P5-P5_1-Mitotic.MkI67_(Mitotic.MkI67)|Globus_pallidus / BrainAtlas - Mouse McCarroll V32 | 4.03e-04 | 161 | 40 | 3 | 28d5dbd20c9f8e0069f172d552997a044790e1a7 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT2_L6_FEZF2-Exc_L6_FEZF2_P4HA3|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.11e-04 | 162 | 40 | 3 | dd4a08af653095ad4f63112312715589a1d43b38 | |
| ToppCell | PBMC-Control-Lymphocyte-T/NK-CD4+_T-Treg-Treg_6|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 4.11e-04 | 162 | 40 | 3 | 6ffcf369d954c20ce036aa1d072cee4e205f728e | |
| ToppCell | PBMC-Control-Lymphocyte-T/NK-CD4+_T-Treg-Treg_6|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 4.11e-04 | 162 | 40 | 3 | bcbf7f80a2a1c80def795e345f16cf16e8b9d03b | |
| ToppCell | LPS-antiTNF-Endothelial-Endothelial-FOXM1|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.18e-04 | 163 | 40 | 3 | 5285318c52aa31c9b22dc2ffff078e32e408604d | |
| Drug | Pronethalol hydrochloride [51-02-5]; Up 200; 15uM; MCF7; HT_HG-U133A | 1.20e-06 | 198 | 40 | 6 | 7322_UP | |
| Drug | trichostatin A, Streptomyces sp.; Down 200; 1uM; PC3; HT_HG-U133A | 1.54e-05 | 180 | 40 | 5 | 6886_DN | |
| Disease | Adenoid Cystic Carcinoma | 9.32e-06 | 100 | 39 | 4 | C0010606 | |
| Disease | stomach carcinoma (is_marker_for) | 4.61e-04 | 24 | 39 | 2 | DOID:5517 (is_marker_for) | |
| Disease | Sezary Syndrome | 5.85e-04 | 27 | 39 | 2 | C0036920 | |
| Disease | cognition | 1.04e-03 | 36 | 39 | 2 | EFO_0003925 | |
| Disease | autism spectrum disorder (implicated_via_orthology) | 1.07e-03 | 152 | 39 | 3 | DOID:0060041 (implicated_via_orthology) | |
| Disease | HVA measurement, 5-HIAA measurement | 1.22e-03 | 39 | 39 | 2 | EFO_0005131, EFO_0005132 | |
| Disease | Prostatic Neoplasms | 1.25e-03 | 616 | 39 | 5 | C0033578 | |
| Disease | Malignant neoplasm of prostate | 1.25e-03 | 616 | 39 | 5 | C0376358 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| HNAQIIVMLPDNQSL | 1241 | P23470 | |
| QLLNIHSNPEMQQQL | 1136 | Q9NYV4 | |
| PLHNVQVLNQMITSK | 161 | O43683 | |
| QQQRMQQHLPLQGSS | 2246 | Q92793 | |
| EVQMSQLVLPCHTNQ | 46 | Q8WXI4 | |
| TPTENMNLLAIQHQA | 111 | Q8IY63 | |
| MEASVQQPSQQQQLL | 516 | Q86VQ1 | |
| QLPQVQNTAMASHLT | 251 | Q9BWF3 | |
| QVKVTPETHMLQQQQ | 391 | Q6ZW49 | |
| MVPQQLQHQQHTTVI | 3306 | Q8NEZ4 | |
| ILSILSQHINSNMPQ | 1351 | Q8IWI9 | |
| HMPSSINLLVQNQQT | 301 | Q86T24 | |
| ISNIRNQMETLHSQP | 286 | Q8N6Q8 | |
| LQIAMQNQINTNPES | 156 | Q06547 | |
| QNQQLRAQLSLMAHP | 681 | Q08379 | |
| NNMPVLEQSVLAHIN | 446 | P29375 | |
| MQQIITNTGEIQQIP | 226 | Q13952 | |
| LIPGTNINTTNQHIM | 416 | Q13093 | |
| IITYPLSMHQQQQLQ | 461 | O75460 | |
| EGQIQQMIRHPNITQ | 111 | P57058 | |
| HNNVLKPINLLSQQM | 1821 | Q5VZ89 | |
| VNPMTQINQVTHDQA | 1181 | Q93008 | |
| HLPSMQQLVQILDNE | 166 | P62341 | |
| IVQNLHSMLPIQQLQ | 406 | Q9UHJ6 | |
| HHNLSPVTQILMQQT | 336 | Q9Y2E8 | |
| IPKISMVNNIIHNNE | 526 | Q8NEM2 | |
| INLLQQQIQVQGHMP | 251 | P35712 | |
| IGTTQHMIQQQTLQS | 616 | O15516 | |
| SLQVSPQEMVQEIHQ | 61 | O75153 | |
| MAHSQNSLELPININ | 1 | Q9UHP6 | |
| QQLIQRNPEISHMLN | 216 | Q9UMX0 | |
| QVSPSVQTQQHQMQL | 431 | O15405 | |
| SEHLDTQQLMQQNPE | 196 | Q8IYU4 | |
| TQVANLPNTVQHMLL | 461 | Q9UGU0 | |
| QIMPFLSQEHQQQVA | 91 | Q04726 | |
| AMQVNQPLQTVLNQL | 771 | Q96T88 | |
| HNTSTLIQPMNQGVI | 321 | Q6NT04 | |
| LHMLQDLVSTNPQQL | 596 | Q9H347 | |
| PMTTETLLQLQQQQH | 1781 | Q15911 | |
| LLVKEHSNPMQVQQQ | 161 | P59046 | |
| HSNPMQVQQQLLDTG | 166 | P59046 |